IP Library › Granted Patent US 11,819,385
Granted Patent B2
US 11,819,385 · App. 16/657,661 · Granted Nov 21, 2023

Systems and methods for tissue healing

Inventor: Jay Sexton (Tucson, AZ)
Assignee: ATOMIC MEDICAL INNOVATIONS, INC.
A61F13/00068A61F13/022A61F13/0216A61F13/0223A61M1/915A61M1/916A61M1/985A61M1/918
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,819,385
App. No.
16/657,661
Granted
Nov 21, 2023
Kind
B2
Abstract

Systems, methods and devices are provided for use in a negative pressure wound therapy system for healing a wound in a patient. Various aspects may include an ester-based material adapted to be directly applied to the wound, such as a smooth muscle fistula, without substantially damaging tissue in the wound during dressing changes. The ester-based material may have an affinity for the wound bed surface and/or wound fluid. In addition, various aspects may include a device adapted to close the wound, such as a smooth muscle fistula.

Claims (17)

1. A wound dressing adapted to be applied to a wound bed including a smooth muscle fistula in a negative pressure treatment system, the wound dressing comprising:

a wound-side layer adapted to be placed directly against the wound bed and to contact smooth muscle without causing substantial cellular disruption or damage in the negative pressure environment, the wound-side layer comprising an ester-based film having pores with a width of about 0.1 μm to about 50 μm;

an intermediate layer adjacent the wound-side layer and comprising a foam having pores the same size or larger than the pores of the ester-based film; and

an occlusive layer adjacent the intermediate layer and opposite the wound-side layer.

2. The wound dressing of claim 1 , wherein the ester-based film is impregnated with a chemical or compound to be applied to the wound bed.

3. The wound dressing of claim 1 , wherein the width of the pores of the ester-based film is from about 0.2 μm to about 2 μm.

4. The wound dressing of claim 1 , wherein the width of the pores of the ester-based film approximates the width of cells at the wound bed.

5. The wound dressing of claim 1 , wherein the width of the pores of the ester-based film approximates the width of cells of an exudate to be drawn from the wound bed.

6. A negative pressure treatment system adapted to treat a wound bed including a smooth muscle fistula, the negative pressure treatment system comprising:

a wound dressing comprising:

a wound-side layer adapted to be placed directly against the wound bed and to contact smooth muscle without causing substantial cellular disruption or damage in the negative pressure environment, the wound-side layer comprising an ester-based matcrial film having pores with a width of about 0.1 μm to about 50 μm; and

an intermediate layer adjacent the wound-side layer and comprising a foam having pores the same size or larger than the pores of the ester-based film; and

an occlusive layer adjacent the wound dressing opposite the wound bed; and

a vacuum pump configured to apply negative pressure to the wound dressing, thereby withdrawing wound fluid from the wound bed.

7. The negative pressure treatment system of claim 6 , wherein the ester-based film is impregnated with a chemical or compound to be applied to the wound bed.

8. The negative pressure treatment system of claim 6 , wherein the width of the pores of the ester-based film is from about 0.2 μm to about 2 μm.

9. The negative pressure treatment system of claim 6 , wherein the width of the pores of the ester-based film approximates at least one of the width of cells at the wound bed or the width of cells of an exudate to be drawn from the wound bed.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 21, 2019
From: SEXTON, JAY
To: ATOMIC MEDICAL INNOVATIONS, INC.
Reel/Frame 050774/0568 →
Continuity (3)
Continuation 15118839
Provisional Application 61940245 · Feb 14, 2014
Related Publication 20200046568A1 · Feb 13, 2020
Cited By (1)
US 12,708,566